PepperLime Health Acquisition Corporation
NASDAQ:PEPL
10.93 (USD) • At close March 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.356 | 0.047 | 0.463 | 0.522 | 0.217 | 0.279 | 0.336 | 0.439 | 0.026 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.356 | 0.047 | 0.463 | 0.522 | 0.217 | 0.279 | 0.336 | 0.439 | 0.026 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 0.356 | 0.047 | 0.463 | 0.522 | 0.217 | 0.279 | 0.336 | 0.439 | 0.026 |
| Operating Income
| -0.356 | -0.047 | -0.463 | -0.522 | -0.217 | -0.279 | -0.336 | -0.439 | -0.026 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.148 | 0.151 | 0.455 | 1.45 | 0.755 | 0.232 | 0.004 | 0.002 | 0 |
| Income Before Tax
| -0.208 | 0.104 | -0.008 | 0.928 | 0.538 | -0.047 | -0.331 | -0.437 | -0.026 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0.455 | -1.008 | -0.648 | -0.232 | -0.004 | -0.002 | 0 |
| Net Income
| -0.208 | 0.104 | 0.447 | 1.936 | 1.186 | 0.185 | -0.327 | -0.437 | -0.026 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.039 | 0.02 | 0.11 | 0.11 | 0.28 | 0.044 | -0.019 | 0 | -0.002 |
| EPS Diluted
| -0.039 | 0.02 | 0.11 | 0.11 | 0.28 | 0.044 | -0.019 | 0 | -0.002 |
| EBITDA
| -0.356 | -0.047 | -0.463 | -0.522 | -0.217 | -0.279 | -0.336 | -0.439 | -0.026 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |